May 7 |
Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
|
May 4 |
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
|
May 4 |
Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its First-Quarter Results
|
May 3 |
Ultragenyx Pharmaceutical Inc (RARE) (Q1 2024) Earnings Call Transcript Highlights: Key ...
|
May 3 |
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
|
May 3 |
Ultragenyx Pharmaceutical, Inc. (RARE) Q1 2024 Earnings Call Transcript
|
May 2 |
Ultragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...
|
May 2 |
Ultragenyx Pharmaceutical GAAP EPS of -$2.03 misses by $0.28, revenue of $108.8M misses by $7.64M
|
May 2 |
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
|
May 1 |
Ultragenyx Pharmaceutical Q1 2024 Earnings Preview
|